See more : Primech Holdings Ltd. Ordinary Shares (PMEC) Income Statement Analysis – Financial Results
Complete financial analysis of Medicale Corp (MCLE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medicale Corp, a leading company in the Food Distribution industry within the Consumer Defensive sector.
- Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) Income Statement Analysis – Financial Results
- Shenzhen Fountain Corporation (000005.SZ) Income Statement Analysis – Financial Results
- East Resources Acquisition Company (ERES) Income Statement Analysis – Financial Results
- LandMark Optoelectronics Corporation (3081.TWO) Income Statement Analysis – Financial Results
- HILIKS TECHNOLOGIES LIMITED (HILIKS.BO) Income Statement Analysis – Financial Results
Medicale Corp (MCLE)
About Medicale Corp
Medicale Corp. distributes dietary supplements and provides consulting services in Georgia. The company, through its website, medicalecorp.com, offers products, such as vitamins, minerals, proteins and amino acids, bodybuilding supplements, essential fatty acids, natural products, probiotics, and other products; and operates a news blog with information related to dietary supplements and healthy lifestyle. Medicale Corp. was founded in 2020 and is based in Tbilisi, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 2.40K | 2.40K | 0.00 |
| Gross Profit | 0.00 | -2.40K | -2.40K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 37.59K | 46.42K | 32.15K | 23.08K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 1.90K |
| SG&A | 37.59K | 46.42K | 32.15K | 1.92K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 37.59K | 46.42K | 32.15K | 1.92K |
| Cost & Expenses | 37.59K | 46.42K | 32.15K | 1.92K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 0.00 | 2.40K | 2.40K | 23.08K |
| EBITDA | -37.59K | -44.02K | -29.75K | 21.15K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -37.59K | -46.42K | -32.15K | -1.92K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | -3.00 |
| Income Before Tax | -37.59K | -46.42K | -32.15K | -1.92K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.00 | -2.00 | -23.08 |
| Net Income | -37.14K | -46.42K | -32.15K | -1.92K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 5.85M | 5.92M | 5.92M | 5.92M |
| Weighted Avg Shares Out (Dil) | 5.92M | 5.92M | 5.92M | 5.92M |
Source: https://incomestatements.info
Category: Stock Reports